• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical pharmacology of isophosphamide.

作者信息

Creaven P J, Allen L M, Alford D A, Cohen M H

出版信息

Clin Pharmacol Ther. 1974 Jul;16(1):77-86. doi: 10.1002/cpt1974161part177.

DOI:10.1002/cpt1974161part177
PMID:4602057
Abstract
摘要

相似文献

1
Clinical pharmacology of isophosphamide.
Clin Pharmacol Ther. 1974 Jul;16(1):77-86. doi: 10.1002/cpt1974161part177.
2
Clinical trial of isophosphamide (NSC-109724)--results and side effects.异环磷酰胺（NSC - 109724）的临床试验——结果与副作用
Cancer Chemother Rep. 1974 Nov-Dec;58(6):889-93.
3
Renal dysfunction after treatment with isophosphamide (NSC-109724).
Cancer Chemother Rep. 1974 May-Jun;58(3):375-82.
4
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):861-5.
5
Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
J Med Chem. 1974 Nov;17(11):1237-9. doi: 10.1021/jm00257a024.
6
A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
Oncology. 1974;29(1):34-9. doi: 10.1159/000224886.
7
Activation of the antineoplastic drug isophosphamide by rat liver microsomes.
J Pharm Pharmacol. 1972 Jul;24(7):585-6. doi: 10.1111/j.2042-7158.1972.tb09065.x.
8
[Clinical evaluation of ifosfamide in the treatment of malignant neoplasms].
Nowotwory. 1973 Jul-Sep;23(3):285-90.
9
Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
Cancer Res. 1972 Nov;32(11):2519-23.
10
[Experiences with single high dosage iphosphamide therapy in metastasizing malignant neoplasms].
Verh Dtsch Ges Inn Med. 1972;78:166-9.

引用本文的文献

1
Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.用于治疗中枢神经系统肿瘤的抗癌药物的药代动力学特性：文献综述
Clin Pharmacokinet. 2016 Mar;55(3):297-311. doi: 10.1007/s40262-015-0319-6.
2
Pharmacokinetic considerations in the treatment of CNS tumours.中枢神经系统肿瘤治疗中的药代动力学考量
Clin Pharmacokinet. 2006;45(9):871-903. doi: 10.2165/00003088-200645090-00002.
3
Mass balance studies, with a focus on anticancer drugs.以抗癌药物为重点的质量平衡研究。
Clin Pharmacokinet. 2006;45(1):33-58. doi: 10.2165/00003088-200645010-00003.
4
The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.大剂量推注和静脉滴注异环磷酰胺时的药代动力学和代谢：一项随机交叉研究。
Br J Cancer. 1998 Mar;77(6):978-84. doi: 10.1038/bjc.1998.161.
5
Determination of the urinary excretion of ifosfamide and its phosphorated metabolites by phosphorus-31 nuclear magnetic resonance spectroscopy.
Cancer Chemother Pharmacol. 1993;31(5):387-94. doi: 10.1007/BF00686153.
6
Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma.异环磷酰胺单药治疗晚期肾癌后的中枢神经系统副作用。
J Cancer Res Clin Oncol. 1981;100(1):113-6. doi: 10.1007/BF00405909.
7
Comparative activity of ifosfamide and cyclophosphamide.异环磷酰胺与环磷酰胺的活性比较
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S1-9. doi: 10.1007/BF00647438.
8
Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children.
Cancer Chemother Pharmacol. 1989;24 Suppl 1:S2-6; discussion S7. doi: 10.1007/BF00253227.
9
The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.癌症患者中短时间和长时间静脉输注异环磷酰胺的药代动力学。
Br J Clin Pharmacol. 1991 Jan;31(1):77-82. doi: 10.1111/j.1365-2125.1991.tb03860.x.
10
Ifosfamide pharmacokinetics.
Invest New Drugs. 1991 Nov;9(4):305-11. doi: 10.1007/BF00183570.